Narcolepsy during Childhood: An Update

 

 Buy Article Permissions and Reprints

Abstract

Narcolepsy type 1 (NT1) is a rare central disorder of hypersomnolence characterized by excessive daytime sleepiness, cataplexy, sleep paralysis, hallucinations, and fragmented nocturnal sleep usually arising in adolescence or young adulthood. Recently, the childhood NT1 diagnoses have increased for improved disease awareness and for several cases occurring after the H1N1 pandemic influenza or vaccination. As in adults, the occurrence of NT1 in individuals with a genetic predisposition of the immune system (e.g., human leukocyte antigen, HLA-DQB1*0602) together with the role of environmental triggers (e.g., H1N1 influenza virus, streptococcus β hemolyticus) further supports the autoimmune pathogenesis. Children with NT1 close to disease onset show a peculiar cataplexy phenotype characterized by persistent hypotonia with prominent facial involvement (cataplectic facies) and by a complex mosaic of hyperkinetic movement abnormalities that increase during emotional stimulation. This phenotype progressively vanishes along the disease course leading to the typical picture of cataplexy (i.e., muscle weakness exclusively evoked by strong emotions). This possibly explains in part the misdiagnoses and diagnostic delay. Childhood NT1 also shows behavioral abnormalities and psychiatric disorders, encompassing depressive feelings, hyperactive/aggressive behavior, up to psychotic features. The association with obesity and precocious puberty strikingly suggests that NT1 arising in prepubertal children may reflect a wide hypothalamic derangement secondary to hypocretin neuronal loss. The complexity of the childhood NT1 phenotype claims a multidisciplinary assessment and management, taking behavioral and endocrinological features into account. NT1 indeed is a lifelong disorder with a devastating impact on quality of life, especially when arising across developmental age, and targeted school programs, medicolegal and psychological supports are essential for patients care. Controlled studies are mandatory to assess safety and efficacy of the current symptomatic off-label medications on which also relies the treatment for children with NT1, and hopefully future pathogenetic evidences will pave the way to better disease prevention and therapies to modify the disease course.

• References

• 1 American Academy of Sleep Medicine. International classification of sleep disorders, 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014
  Google Scholar
• 2 Peyron C, Faraco J, Rogers W , et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000; 6 (9) 991-997
  CrossrefPubMedGoogle Scholar
• 3 Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000; 355 (9197) 39-40
  CrossrefPubMedGoogle Scholar
• 4 Partinen M, Kornum BR, Plazzi G, Jennum P, Julkunen I, Vaarala O. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol 2014; 13 (6) 600-613
  CrossrefPubMedGoogle Scholar
• 5 Partinen M, Saarenpää-Heikkilä O, Ilveskoski I , et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS ONE 2012; 7 (3) e33723
  CrossrefPubMedGoogle Scholar
• 6 Nohynek H, Jokinen J, Partinen M , et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS ONE 2012; 7 (3) e33536
  CrossrefPubMedGoogle Scholar
• 7 Han F, Lin L, Warby SC , et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 2011; 70 (3) 410-417
  CrossrefPubMedGoogle Scholar
• 8 Han F, Lin L, Li J, Dong XS, Mignot E. Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic. Ann Neurol 2013; 73 (4) 560
  CrossrefPubMedGoogle Scholar
• 9 Aran A, Einen M, Lin L, Plazzi G, Nishino S, Mignot E. Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children. Sleep 2010; 33 (11) 1457-1464
  CrossrefPubMedGoogle Scholar
• 10 Plazzi G, Pizza F, Palaia V , et al. Complex movement disorders at disease onset in childhood narcolepsy with cataplexy. Brain 2011; 134 (Pt 12): 3480-3492
  CrossrefPubMedGoogle Scholar
• 11 Kornum BR, Faraco J, Mignot E. Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain. Curr Opin Neurobiol 2011; 21 (6) 897-903
  CrossrefPubMedGoogle Scholar
• 12 Natarajan N, Jain SV, Chaudhry H, Hallinan BE, Simakajornboon N. Narcolepsy-cataplexy: is streptococcal infection a trigger?. J Clin Sleep Med 2013; 9 (3) 269-270
  PubMedGoogle Scholar
• 13 Dias Costa F, Barreto MI, Clemente V, Vasconcelos M, Estevao MH, Madureira N. Narcolepsy in pediatric age – Experience of a tertiary pediatric hospital. Sleep Science 2014; 7 (1) 53-58
  CrossrefPubMedGoogle Scholar
• 14 Dauvilliers Y, Montplaisir J, Molinari N , et al. Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology 2001; 57 (11) 2029-2033
  CrossrefPubMedGoogle Scholar
• 15 Thorpy MJ, Krieger AC. Delayed diagnosis of narcolepsy: characterization and impact. Sleep Med 2014; 15 (5) 502-507
  CrossrefPubMedGoogle Scholar
• 16 Longstreth Jr WT, Koepsell TD, Ton TG, Hendrickson AF, van Belle G. The epidemiology of narcolepsy. Sleep 2007; 30 (1) 13-26
  CrossrefPubMedGoogle Scholar
• 17 Ohayon MM, Priest RG, Zulley J, Smirne S, Paiva T. Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology 2002; 58 (12) 1826-1833
  CrossrefPubMedGoogle Scholar
• 18 Silber MH, Krahn LE, Olson EJ, Pankratz VS. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep 2002; 25 (2) 197-202
  PubMedGoogle Scholar
• 19 Wijnans L, Lecomte C, de Vries C , et al. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine 2013; 31 (8) 1246-1254
  CrossrefPubMedGoogle Scholar
• 20 Luca G, Haba-Rubio J, Dauvilliers Y , et al; European Narcolepsy Network. Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study. J Sleep Res 2013; 22 (5) 482-495 10.1111/jsr.12044
  CrossrefPubMedGoogle Scholar
• 21 McKenna L, McNicholas F. Childhood onset narcolepsy—a case report. Eur Child Adolesc Psychiatry 2003; 12 (1) 43-47
  CrossrefPubMedGoogle Scholar
• 22 Morrish E, King MA, Smith IE, Shneerson JM. Factors associated with a delay in the diagnosis of narcolepsy. Sleep Med 2004; 5 (1) 37-41
  CrossrefPubMedGoogle Scholar
• 23 Serra L, Montagna P, Mignot E, Lugaresi E, Plazzi G. Cataplexy features in childhood narcolepsy. Mov Disord 2008; 23 (6) 858-865
  CrossrefPubMedGoogle Scholar
• 24 Poli F, Pizza F, Mignot E , et al. High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy. Sleep 2013; 36 (2) 175-181
  PubMedGoogle Scholar
• 25 Pizza F, Peltola H, Sarkanen T, Moghadam KK, Plazzi G, Partinen M. Childhood narcolepsy with cataplexy: comparison between post-H1N1 vaccination and sporadic cases. Sleep Med 2014; 15 (2) 262-265
  CrossrefPubMedGoogle Scholar
• 26 Ohayon MM, Ferini-Strambi L, Plazzi G, Smirne S, Castronovo V. How age influences the expression of narcolepsy. J Psychosom Res 2005; 59 (6) 399-405
  CrossrefPubMedGoogle Scholar
• 27 Wise MS, Lynch J. Narcolepsy in children. Semin Pediatr Neurol 2001; 8 (4) 198-206
  CrossrefPubMedGoogle Scholar
• 28 Plazzi G, Khatami R, Serra L, Pizza F, Bassetti CL. Pseudocataplexy in narcolepsy with cataplexy. Sleep Med 2010; 11 (6) 591-594
  PubMedGoogle Scholar
• 29 Peterson PC, Husain AM. Pediatric narcolepsy. Brain Dev 2008; 30 (10) 609-623
  CrossrefPubMedGoogle Scholar
• 30 Kotagal S. Narcolepsy in children. Semin Pediatr Neurol 1996; 3 (1) 36-43
  CrossrefPubMedGoogle Scholar
• 31 Challamel MJ, Mazzola ME, Nevsimalova S, Cannard C, Louis J, Revol M. Narcolepsy in children. Sleep 1994; 17 (8, Suppl): S17-S20
  PubMedGoogle Scholar
• 32 Nevsimalova S, Prihodova I, Kemlink D, Lin L, Mignot E. REM behavior disorder (RBD) can be one of the first symptoms of childhood narcolepsy. Sleep Med 2007; 8 (7–8) 784-786
  CrossrefPubMedGoogle Scholar
• 33 Dahl RE, Holttum J, Trubnick L. A clinical picture of child and adolescent narcolepsy. J Am Acad Child Adolesc Psychiatry 1994; 33 (6) 834-841
  CrossrefPubMedGoogle Scholar
• 34 Wise MS. Childhood narcolepsy. Neurology 1998; 50 (2) (Suppl. 01) S37-S42
  CrossrefPubMedGoogle Scholar
• 35 Guilleminault C, Pelayo R. Narcolepsy in prepubertal children. Ann Neurol 1998; 43 (1) 135-142
  CrossrefPubMedGoogle Scholar
• 36 Broughton WA, Broughton RJ. Psychosocial impact of narcolepsy. Sleep 1994; 17 (8, Suppl): S45-S49
  PubMedGoogle Scholar
• 37 Hayes Jr D. Narcolepsy with cataplexy in early childhood. Clin Pediatr (Phila) 2006; 45 (4) 361-363
  CrossrefPubMedGoogle Scholar
• 38 Dorris L, Zuberi SM, Scott N, Moffat C, McArthur I. Psychosocial and intellectual functioning in childhood narcolepsy. Dev Neurorehabil 2008; 11 (3) 187-194
  CrossrefPubMedGoogle Scholar
• 39 Pizza F, Franceschini C, Peltola H , et al. Clinical and polysomnographic course of childhood narcolepsy with cataplexy. Brain 2013; 136 (Pt 12) 3787-3795
  CrossrefPubMedGoogle Scholar
• 40 Yoss RE, Daly DD. Narcolepsy in children. Pediatrics 1960; 25: 1025-1033
  PubMedGoogle Scholar
• 41 Young D, Zorick F, Wittig R, Roehrs T, Roth T. Narcolepsy in a pediatric population. Am J Dis Child 1988; 142 (2) 210-213
  PubMedGoogle Scholar
• 42 Kotagal S, Hartse KM, Walsh JK. Characteristics of narcolepsy in preteenaged children. Pediatrics 1990; 85 (2) 205-209
  PubMedGoogle Scholar
• 43 Reimão R, Lemmi H. Narcolepsy in childhood and adolescence. Arq Neuropsiquiatr 1991; 49 (3) 260-264
  CrossrefPubMedGoogle Scholar
• 44 Allsopp MR, Zaiwalla Z. Narcolepsy. Arch Dis Child 1992; 67 (3) 302-306
  CrossrefPubMedGoogle Scholar
• 45 Han F, Chen E, Wei H , et al. Childhood narcolepsy in North China. Sleep 2001; 24 (3) 321-324
  PubMedGoogle Scholar
• 46 Pelin Z, Bozluolcay M, Kaynak D, Kaynak H. Childhood onset of narcolepsy-cataplexy syndrome in Turkey: clinical and genetic study. Turk J Pediatr 2002; 44 (4) 321-325
  PubMedGoogle Scholar
• 47 Arii J, Kanbayashi T, Tanabe Y , et al. CSF hypocretin-1 (orexin-A) levels in childhood narcolepsy and neurologic disorders. Neurology 2004; 63 (12) 2440-2442
  PubMedGoogle Scholar
• 48 Kotagal S, Krahn LE, Slocumb N. A putative link between childhood narcolepsy and obesity. Sleep Med 2004; 5 (2) 147-150
  CrossrefPubMedGoogle Scholar
• 49 Vendrame M, Havaligi N, Matadeen-Ali C, Adams R, Kothare SV. Narcolepsy in children: a single-center clinical experience. Pediatr Neurol 2008; 38 (5) 314-320
  CrossrefPubMedGoogle Scholar
• 50 Nevsimalova S, Buskova J, Kemlink D, Sonka K, Skibova J. Does age at the onset of narcolepsy influence the course and severity of the disease?. Sleep Med 2009; 10 (9) 967-972
  CrossrefPubMedGoogle Scholar
• 51 Peraita-Adrados R, García-Peñas JJ, Ruiz-Falcó L , et al. Clinical, polysomnographic and laboratory characteristics of narcolepsy-cataplexy in a sample of children and adolescents. Sleep Med 2011; 12 (1) 24-27
  CrossrefPubMedGoogle Scholar
• 52 Nevsimalova S, Jara C, Prihodova I, Kemlink D, Sonka K, Skibova J. Clinical features of childhood narcolepsy. Can cataplexy be foretold?. Eur J Paediatr Neurol 2011; 15 (4) 320-325
  CrossrefPubMedGoogle Scholar
• 53 Jambhekar SK, Com G, Jones E , et al. Periodic limb movements during sleep in children with narcolepsy. J Clin Sleep Med 2011; 7 (6) 597-601
  PubMedGoogle Scholar
• 54 Kauta SR, Marcus CL. Cases of pediatric narcolepsy after misdiagnoses. Pediatr Neurol 2012; 47 (5) 362-365
  CrossrefPubMedGoogle Scholar
• 55 Mansukhani MP, Kotagal S. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study. Sleep Med 2012; 13 (6) 606-610
  CrossrefPubMedGoogle Scholar
• 56 Heier MS, Gautvik KM, Wannag E , et al. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med 2013; 14 (9) 867-871
  CrossrefPubMedGoogle Scholar
• 57 Dong XS, Ma SF, Cao CW , et al. Hypocretin (orexin) neuropeptide precursor gene, HCRT, polymorphisms in early-onset narcolepsy with cataplexy. Sleep Med 2013; 14 (6) 482-487
  CrossrefPubMedGoogle Scholar
• 58 Szakács A, Darin N, Hallböök T. Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination. Neurology 2013; 80 (14) 1315-1321
  CrossrefPubMedGoogle Scholar
• 59 Zandieh S, Ramgopal S, Khatwa U , et al. The maintenance of wakefulness test in pediatric narcolepsy. Pediatr Neurol 2013; 48 (6) 443-446
  CrossrefPubMedGoogle Scholar
• 60 Huang YS, Guilleminault C, Chen CH, Lai PC, Hwang FM. Narcolepsy-cataplexy and schizophrenia in adolescents. Sleep Med 2014; 15 (1) 15-22
  CrossrefPubMedGoogle Scholar
• 61 Inocente CO, Lavault S, Lecendreux M , et al. Impact of obesity in children with narcolepsy. CNS Neurosci Ther 2013; 19 (7) 521-528
  CrossrefPubMedGoogle Scholar
• 62 Inocente CO, Gustin MP, Lavault S , et al. Quality of life in children with narcolepsy. CNS Neurosci Ther 2014; 20 (8) 763-771
  CrossrefPubMedGoogle Scholar
• 63 Posar A, Pizza F, Parmeggiani A, Plazzi G. Neuropsychological findings in childhood narcolepsy. J Child Neurol 2014; 29 (10) 1370-1376
  CrossrefPubMedGoogle Scholar
• 64 Szakács A, Hallböök T, Tideman P, Darin N, Wentz E. Psychiatric comorbidity and cognitive profile in children with narcolepsy with or without association to the H1N1 influenza vaccination. Sleep 2015; 38 (4) 615-621
  PubMedGoogle Scholar
• 65 Vaarala O, Vuorela A, Partinen M , et al. Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: Implications for pandemrix-associated narcolepsy risk. PLoS ONE 2014; 9 (12) e114361
  CrossrefPubMedGoogle Scholar
• 66 Winstone AM, Stellitano L, Verity C , et al. Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England. Dev Med Child Neurol 2014; 56 (11) 1117-1123
  CrossrefPubMedGoogle Scholar
• 67 Dhondt K, Verhelst H, Pevernagie D, Slap F, Van Coster R. Childhood narcolepsy with partial facial cataplexy: a diagnostic dilemma. Sleep Med 2009; 10 (7) 797-798
  CrossrefPubMedGoogle Scholar
• 68 Aran A, Lin L, Nevsimalova S , et al. Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep 2009; 32 (8) 979-983
  PubMedGoogle Scholar
• 69 Nevsimalova S. The diagnosis and treatment of pediatric narcolepsy. Curr Neurol Neurosci Rep 2014; 14 (8) 469
  CrossrefPubMedGoogle Scholar
• 70 Jardri R, Bartels-Velthuis AA, Debbané M , et al. From phenomenology to neurophysiological understanding of hallucinations in children and adolescents. Schizophr Bull 2014; 40 (Suppl. 04) S221-S232
  CrossrefPubMedGoogle Scholar
• 71 Pisko J, Pastorek L, Buskova J, Sonka K, Nevsimalova S. Nightmares in narcolepsy: underinvestigated symptom?. Sleep Med 2014; 15 (8) 967-972
  CrossrefPubMedGoogle Scholar
• 72 Franceschini C, Ferri R, Pizza F , et al. Motor events during REM sleep in patients with narcolepsy-cataplexy: a video-polysomnographic pilot study. Sleep Med 2011; 12 (Suppl. 02) S59-S63
  PubMedGoogle Scholar
• 73 Baiardi S, Pizza F, Vandi S , et al. Cataplectic attacks during rapid eye movement sleep behavior disorder episodes in a narcoleptic patient. Sleep Med 2014; 15 (2) 273-275
  CrossrefPubMedGoogle Scholar
• 74 Fortuyn HA, Lappenschaar MA, Furer JW , et al. Anxiety and mood disorders in narcolepsy: a case-control study. Gen Hosp Psychiatry 2010; 32 (1) 49-56
  CrossrefPubMedGoogle Scholar
• 75 Pizza F, Magnani M, Indrio C, Plazzi G. The hypocretin system and psychiatric disorders. Curr Psychiatry Rep 2014; 16 (2) 433
  CrossrefPubMedGoogle Scholar
• 76 Ohayon MM. Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population. Sleep Med 2013; 14 (6) 488-492
  CrossrefPubMedGoogle Scholar
• 77 Modestino EJ, Winchester J. A retrospective survey of childhood ADHD symptomatology among adult narcoleptics. J Atten Disord 2013; 17 (7) 574-582
  CrossrefPubMedGoogle Scholar
• 78 Guilleminault C, Pelayo R. Narcolepsy in children: a practical guide to its diagnosis, treatment and follow-up. Paediatr Drugs 2000; 2 (1) 1-9
  CrossrefPubMedGoogle Scholar
• 79 Fortuyn HA, Lappenschaar GA, Nienhuis FJ , et al. Psychotic symptoms in narcolepsy: phenomenology and a comparison with schizophrenia. Gen Hosp Psychiatry 2009; 31 (2) 146-154
  CrossrefPubMedGoogle Scholar
• 80 Inocente CO, Gustin MP, Lavault S , et al. Depressive feelings in children with narcolepsy. Sleep Med 2014; 15 (3) 309-314
  CrossrefPubMedGoogle Scholar
• 81 Fortuyn HA, Mulders PC, Renier WO, Buitelaar JK, Overeem S. Narcolepsy and psychiatry: an evolving association of increasing interest. Sleep Med 2011; 12 (7) 714-719
  CrossrefPubMedGoogle Scholar
• 82 Zamarian L, Högl B, Delazer M , et al. Subjective deficits of attention, cognition and depression in patients with narcolepsy. Sleep Med 2015; 16 (1) 45-51
  CrossrefPubMedGoogle Scholar
• 83 Vignatelli L, Plazzi G, Peschechera F, Delaj L, D'Alessandro R. A 5-year prospective cohort study on health-related quality of life in patients with narcolepsy. Sleep Med 2011; 12 (1) 19-23
  CrossrefPubMedGoogle Scholar
• 84 Palaia V, Poli F, Pizza F , et al. Narcolepsy with cataplexy associated with nocturnal compulsive behaviors: a case-control study. Sleep 2011; 34 (10) 1365-1371
  PubMedGoogle Scholar
• 85 Naumann A, Bellebaum C, Daum I. Cognitive deficits in narcolepsy. J Sleep Res 2006; 15 (3) 329-338
  CrossrefPubMedGoogle Scholar
• 86 Bayard S, Croisier Langenier M, Cochen De Cock V, Scholz S, Dauvilliers Y. Executive control of attention in narcolepsy. PLoS ONE 2012; 7 (4) e33525
  CrossrefPubMedGoogle Scholar
• 87 Tsujino N, Sakurai T. Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol Rev 2009; 61 (2) 162-176
  CrossrefPubMedGoogle Scholar
• 88 Plazzi G, Parmeggiani A, Mignot E , et al. Narcolepsy-cataplexy associated with precocious puberty. Neurology 2006; 66 (10) 1577-1579
  CrossrefPubMedGoogle Scholar
• 89 Russell SH, Small CJ, Kennedy AR , et al. Orexin A interactions in the hypothalamo-pituitary gonadal axis. Endocrinology 2001; 142 (12) 5294-5302
  CrossrefPubMedGoogle Scholar
• 90 Ferguson AV, Samson WK. The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function. Front Neuroendocrinol 2003; 24 (3) 141-150
  CrossrefPubMedGoogle Scholar
• 91 Ohno K, Sakurai T. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness. Front Neuroendocrinol 2008; 29 (1) 70-87
  CrossrefPubMedGoogle Scholar
• 92 Ripley B, Overeem S, Fujiki N , et al. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 2001; 57 (12) 2253-2258
  CrossrefPubMedGoogle Scholar
• 93 Nishino S, Kanbayashi T. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev 2005; 9 (4) 269-310
  CrossrefPubMedGoogle Scholar
• 94 Bourgin P, Zeitzer JM, Mignot E. CSF hypocretin-1 assessment in sleep and neurological disorders. Lancet Neurol 2008; 7 (7) 649-662
  CrossrefPubMedGoogle Scholar
• 95 Denoix C, Rodriguez-Lafrasse C, Vanier MT, Navelet Y, Landrieu P. Cataplexy revealing an atypical form of Niemann-Pick disease type C [in French]. Arch Fr Pediatr 1991; 48 (1) 31-34
  PubMedGoogle Scholar
• 96 Boor R, Reitter B. Cataplexy in type C Niemann-Pick disease [in German]. Klin Padiatr 1997; 209 (2) 88-90
  Article in Thieme ConnectPubMedGoogle Scholar
• 97 Smit LS, Lammers GJ, Catsman-Berrevoets CE. Cataplexy leading to the diagnosis of Niemann-Pick disease type C. Pediatr Neurol 2006; 35 (1) 82-84
  CrossrefPubMedGoogle Scholar
• 98 Vankova J, Stepanova I, Jech R , et al. Sleep disturbances and hypocretin deficiency in Niemann-Pick disease type C. Sleep 2003; 26 (4) 427-430
  PubMedGoogle Scholar
• 99 Kanbayashi T, Abe M, Fujimoto S , et al. Hypocretin deficiency in niemann-pick type C with cataplexy. Neuropediatrics 2003; 34 (1) 52-53
  Article in Thieme ConnectPubMedGoogle Scholar
• 100 Oyama K, Takahashi T, Shoji Y , et al. Niemann-Pick disease type C: cataplexy and hypocretin in cerebrospinal fluid. Tohoku J Exp Med 2006; 209 (3) 263-267
  CrossrefPubMedGoogle Scholar
• 101 Clarke DJ, Waters J, Corbett JA. Adults with Prader-Willi syndrome: abnormalities of sleep and behaviour. J R Soc Med 1989; 82 (1) 21-24
  PubMedGoogle Scholar
• 102 Nevsimalova S, Vankova J, Stepanova I, Seemanova E, Mignot E, Nishino S. Hypocretin deficiency in Prader-Willi syndrome. Eur J Neurol 2005; 12 (1) 70-72
  CrossrefPubMedGoogle Scholar
• 103 Cotton S, Richdale A. Brief report: parental descriptions of sleep problems in children with autism, Down syndrome, and Prader-Willi syndrome. Res Dev Disabil 2006; 27 (2) 151-161
  CrossrefPubMedGoogle Scholar
• 104 Camfferman D, McEvoy RD, O'Donoghue F, Lushington K. Prader Willi Syndrome and excessive daytime sleepiness. Sleep Med Rev 2008; 12 (1) 65-75
  CrossrefPubMedGoogle Scholar
• 105 Maas AP, Sinnema M, Didden R , et al. Sleep disturbances and behavioural problems in adults with Prader-Willi syndrome. J Intellect Disabil Res 2010; 54 (10) 906-917
  CrossrefPubMedGoogle Scholar
• 106 Cassidy SB, McKillop JA, Morgan WJ. Sleep disorders in the Prader-Willi syndrome. 1989 David W Smith Workshop on Malformations and Morphogenesis, Madrid, Spain. Proc Greenwood Genet Centre 1990; 9: 74-5
  PubMedGoogle Scholar
• 107 Tobias ES, Tolmie JL, Stephenson JB. Cataplexy in the Prader-Willi syndrome. Arch Dis Child 2002; 87 (2) 170
  CrossrefPubMedGoogle Scholar
• 108 Weselake SV, Foulds JL, Couch R, Witmans MB, Rubin D, Haqq AM. Prader-Willi syndrome, excessive daytime sleepiness, and narcoleptic symptoms: a case report. J Med Case Reports 2014; 8: 127
  CrossrefPubMedGoogle Scholar
• 109 Mignot E, Lammers GJ, Ripley B , et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002; 59 (10) 1553-1562
  CrossrefPubMedGoogle Scholar
• 110 Dauvilliers Y, Baumann CR, Carlander B , et al. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry 2003; 74 (12) 1667-1673
  CrossrefPubMedGoogle Scholar
• 111 Martínez-Rodríguez JE, Lin L, Iranzo A , et al. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness. Sleep 2003; 26 (3) 287-290
  PubMedGoogle Scholar
• 112 Ciafaloni E, Mignot E, Sansone V , et al. The hypocretin neurotransmission system in myotonic dystrophy type 1. Neurology 2008; 70 (3) 226-230
  CrossrefPubMedGoogle Scholar
• 113 Crow YJ, Zuberi SM, McWilliam R , et al. “Cataplexy” and muscle ultrasound abnormalities in Coffin-Lowry syndrome. J Med Genet 1998; 35 (2) 94-98
  CrossrefPubMedGoogle Scholar
• 114 Fryns JP, Smeets E. “Cataplexy” in Coffin-Lowry syndrome. J Med Genet 1998; 35 (8) 702
  PubMedGoogle Scholar
• 115 Fryssira H, Kountoupi S, Delaunoy JP, Thomaidis L. A female with Coffin-Lowry syndrome and “cataplexy”. Genet Couns 2002; 13 (4) 405-409
  PubMedGoogle Scholar
• 116 Stephenson JB, Hoffman MC, Russell AJ , et al. The movement disorders of Coffin-Lowry syndrome. Brain Dev 2005; 27 (2) 108-113
  CrossrefPubMedGoogle Scholar
• 117 Parkes JD. Genetic factors in human sleep disorders with special reference to Norrie disease, Prader-Willi syndrome and Moebius syndrome. J Sleep Res 1999; 8 (Suppl. 01) 14-22
  CrossrefPubMedGoogle Scholar
• 118 Tyagi A, Harrington H. Cataplexy in association with Moebius syndrome. J Neurol 2003; 250 (1) 110-111
  CrossrefPubMedGoogle Scholar
• 119 Krämer S, Goldammer U, Sindern E. Moebius syndrome and narcolepsy [in German]. Nervenarzt 2014; 85 (12) 1569-1572
  CrossrefPubMedGoogle Scholar
• 120 Dhondt K, Verloo P, Verhelst H, Van Coster R, Overeem S. Hypocretin-1 deficiency in a girl with ROHHAD syndrome. Pediatrics 2013; 132 (3) e788-e792
  CrossrefPubMedGoogle Scholar
• 121 Plazzi G, Tonon C, Rubboli G , et al. Narcolepsy with cataplexy associated with holoprosencephaly misdiagnosed as epileptic drop attacks. Mov Disord 2010; 25 (6) 788-790
  CrossrefPubMedGoogle Scholar
• 122 Pelidou SH, Giannopoulos S, Lagos G, Kyritsis AP. Agenesis of the corpus callosum associated with narcolepsy-cataplexy. Sleep Med 2009; 10 (2) 256-258
  CrossrefPubMedGoogle Scholar
• 123 Zeman A, Douglas N, Aylward R. Lesson of the week: Narcolepsy mistaken for epilepsy. BMJ 2001; 322 (7280) 216-218
  CrossrefPubMedGoogle Scholar
• 124 Macleod S, Ferrie C, Zuberi SM. Symptoms of narcolepsy in children misinterpreted as epilepsy. Epileptic Disord 2005; 7 (1) 13-17
  PubMedGoogle Scholar
• 125 Pizza F, Vandi S, Poli F , et al. Narcolepsy with cataplexy mimicry: the strange case of two sisters. J Clin Sleep Med 2013; 9 (6) 611-612
  PubMedGoogle Scholar
• 126 Shankar R, Jalihal V, Walker M, Zeman A. Pseudocataplexy and transient functional paralysis: a spectrum of psychogenic motor disorder. J Neuropsychiatry Clin Neurosci 2010; 22 (4) 445-450
  CrossrefPubMedGoogle Scholar
• 127 Rubboli G, d'Orsi G, Zaniboni A , et al. A video-polygraphic analysis of the cataplectic attack. Clin Neurophysiol 2000; 111 (Suppl. 02) S120-S128
  CrossrefPubMedGoogle Scholar
• 128 Vetrugno R, D'Angelo R, Moghadam KK , et al. Behavioural and neurophysiological correlates of human cataplexy: a video-polygraphic study. Clin Neurophysiol 2010; 121 (2) 153-162
  CrossrefPubMedGoogle Scholar
• 129 Overeem S, van Nues SJ, van der Zande WL, Donjacour CE, van Mierlo P, Lammers GJ. The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency. Sleep Med 2011; 12 (1) 12-18
  CrossrefPubMedGoogle Scholar
• 130 Melendres MC, Lutz JM, Rubin ED, Marcus CL. Daytime sleepiness and hyperactivity in children with suspected sleep-disordered breathing. Pediatrics 2004; 114 (3) 768-775
  CrossrefPubMedGoogle Scholar
• 131 Drake C, Nickel C, Burduvali E, Roth T, Jefferson C, Pietro B. The pediatric daytime sleepiness scale (PDSS): sleep habits and school outcomes in middle-school children. Sleep 2003; 26 (4) 455-458
  PubMedGoogle Scholar
• 132 Murali H, Kotagal S. Off-label treatment of severe childhood narcolepsy-cataplexy with sodium oxybate. Sleep 2006; 29 (8) 1025-1029
  PubMedGoogle Scholar
• 133 Guilleminault C, Mignot E, Partinen M. Controversies in the diagnosis of narcolepsy. Sleep 1994; 17 (8, Suppl): S1-S6
  PubMedGoogle Scholar
• 134 Carskadon MA, Harvey K, Duke P, Anders TF, Litt IF, Dement WC. Pubertal changes in daytime sleepiness. Sleep 1980; 2 (4) 453-460
  PubMedGoogle Scholar
• 135 Dauvilliers Y, Gosselin A, Paquet J, Touchon J, Billiard M, Montplaisir J. Effect of age on MSLT results in patients with narcolepsy-cataplexy. Neurology 2004; 62 (1) 46-50
  CrossrefPubMedGoogle Scholar
• 136 Reiter J, Katz E, Scammell TE, Maski K. Usefulness of a Nocturnal SOREMP for Diagnosing Narcolepsy with Cataplexy in a Pediatric Population. Sleep 2014; ; e-pub ahead of print
  PubMedGoogle Scholar
• 137 Lamphere J, Young D, Roehrs T, Wittig RM, Zorick F, Roth T. Fragmented sleep, daytime somnolence and age in narcolepsy. Clin Electroencephalogr 1989; 20 (1) 49-54
  CrossrefPubMedGoogle Scholar
• 138 Ferri R, Franceschini C, Zucconi M , et al. Sleep polygraphic study of children and adolescents with narcolepsy/cataplexy. Dev Neuropsychol 2009; 34 (5) 523-538
  CrossrefPubMedGoogle Scholar
• 139 Poli F, Overeem S, Lammers GJ , et al. Narcolepsy as an adverse event following immunization: case definition and guidelines for data collection, analysis and presentation. Vaccine 2013; 31 (6) 994-1007
  CrossrefPubMedGoogle Scholar
• 140 Juji T, Satake M, Honda Y, Doi Y. HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. Tissue Antigens 1984; 24 (5) 316-319
  CrossrefPubMedGoogle Scholar
• 141 Miyagawa T, Kawashima M, Nishida N , et al. Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat Genet 2008; 40 (11) 1324-1328
  CrossrefPubMedGoogle Scholar
• 142 Hallmayer J, Faraco J, Lin L , et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 2009; 41 (6) 708-711
  CrossrefPubMedGoogle Scholar
• 143 Kornum BR, Kawashima M, Faraco J , et al. Common variants in P2RY11 are associated with narcolepsy. Nat Genet 2011; 43 (1) 66-71
  CrossrefPubMedGoogle Scholar
• 144 Mignot E. Genetic and familial aspects of narcolepsy. Neurology 1998; 50 (2) (Suppl. 01) S16-S22
  CrossrefPubMedGoogle Scholar
• 145 Koepsell TD, Longstreth WT, Ton TGN. Medical exposures in youth and the frequency of narcolepsy with cataplexy: a population-based case-control study in genetically predisposed people. J Sleep Res 2010; 19 (1 Pt 1): 80-86
  CrossrefPubMedGoogle Scholar
• 146 Lakemedelsverket Medical Products Agency. Occurrence of narcolepsy with cataplexy among children and adolescents in relation to the H1N1 pandemic and pandemrix vaccinations—results of a case inventory study by the MPA in Sweden during 2009–2010. Available at: https://www.lakemedelsverket.se/upload/nyheter/2011/Fallinventeringsrapport_pandermrix_110630.pdf . Accessed: April 14, 2015
  PubMedGoogle Scholar
• 147 Scammell TE, Estabrooke IV, McCarthy MT , et al. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 2000; 20 (22) 8620-8628
  PubMedGoogle Scholar
• 148 Lecendreux M, Bruni O, Franco P , et al. Clinical experience suggests that modafinil is an effective and safe treatment for paediatric narcolepsy. J Sleep Res 2012; 21 (4) 481-483
  CrossrefPubMedGoogle Scholar
• 149 Guilleminault C, Abad VC. Narcolepsy. In: Chokroverty S. Sleep Disorders Medicine: Basic Science, Technical Considerations, and Clinical Aspects. 3rd ed. Philadelphia: Saunders/Elsevier; 2009: 377-396
  Google Scholar
• 150 Lecendreux M, Poli F, Oudiette D , et al. Tolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: a retrospective study. Sleep 2012; 35 (5) 709-711
  PubMedGoogle Scholar
• 151 Poli F, Ricotta L, Vandi S , et al. Catathrenia under sodium oxybate in narcolepsy with cataplexy. Sleep Breath 2012; 16 (2) 427-434
  CrossrefPubMedGoogle Scholar
• 152 Nishino S, Okuro M. Emerging treatments for narcolepsy and its related disorders. Expert Opin Emerg Drugs 2010; 15 (1) 139-158
  CrossrefPubMedGoogle Scholar
• 153 Guilleminault C, Cao MT. In: Kryger MH, Roth T, Dement WC. Principles and practice of sleep medicine. 5th ed. Philadelphia, PA: Elsevier Saunders; 2011: 957-968
  Crossref
• 154 Lecendreux M, Maret S, Bassetti C, Mouren MC, Taffin M. Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old-boy. J Sleep Res 2003; 12 (4) 347-348
  CrossrefPubMedGoogle Scholar
• 155 Dauvilliers Y, Carlander B, Rivier F, Touchon J, Tafti M. Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann Neurol 2004; 56 (6) 905-908
  CrossrefPubMedGoogle Scholar
• 156 Dauvilliers Y. Follow-up of four narcolepsy patients treated with intravenous immunoglobulins. Ann Neurol 2006; 60 (1) 153
  CrossrefPubMedGoogle Scholar
• 157 Plazzi G, Poli F, Franceschini C , et al. Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy. J Neurol 2008; 255 (10) 1549-1554
  CrossrefPubMedGoogle Scholar
• 158 Hecht M, Lin L, Kushida CA , et al. Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy. Sleep 2003; 26 (7) 809-810
  PubMedGoogle Scholar
• 159 Chen W, Black J, Call P, Mignot E. Late-onset narcolepsy presenting as rapidly progressing muscle weakness: response to plasmapheresis. Ann Neurol 2005; 58 (3) 489-490
  CrossrefPubMedGoogle Scholar
• 160 Fujiki N, Yoshida Y, Ripley B, Mignot E, Nishino S. Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog. Sleep 2003; 26 (8) 953-959
  PubMedGoogle Scholar
• 161 Dhuria SV, Hanson LR, Frey WH. Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system. J Pharm Sci 2009; 98 (7) 2501-2515
  CrossrefPubMedGoogle Scholar
• 162 Mignot E, Nishino S. Emerging therapies in narcolepsy-cataplexy. Sleep 2005; 28 (6) 754-763
  PubMedGoogle Scholar
• 163 Nishino S, Sakurai E, Nevsimalova S , et al. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls. Sleep 2009; 32 (2) 175-180
  PubMedGoogle Scholar
• 164 Kanbayashi T, Kodama T, Kondo H , et al. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome. Sleep 2009; 32 (2) 181-187
  PubMedGoogle Scholar
• 165 Lin JS, Dauvilliers Y, Arnulf I , et al. An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients. Neurobiol Dis 2008; 30 (1) 74-83
  CrossrefPubMedGoogle Scholar
• 166 Dauvilliers Y, Bassetti C, Lammers GJ , et al; HARMONY I study group. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Lancet Neurol 2013; 12 (11) 1068-1075
  CrossrefPubMedGoogle Scholar